0001209191-20-057329.txt : 20201106 0001209191-20-057329.hdr.sgml : 20201106 20201106173739 ACCESSION NUMBER: 0001209191-20-057329 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201104 FILED AS OF DATE: 20201106 DATE AS OF CHANGE: 20201106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEST JEFFREY N CENTRAL INDEX KEY: 0001244921 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06639 FILM NUMBER: 201295466 MAIL ADDRESS: STREET 1: 6950 COLUMBIA GATEWAY DR STE 400 CITY: COLUMBIA STATE: MD ZIP: 21046 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAGELLAN HEALTH INC CENTRAL INDEX KEY: 0000019411 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 581076937 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4801 E. WASHINGTON ST CITY: PHOENIX STATE: AZ ZIP: 85034 BUSINESS PHONE: 800-642-1716 MAIL ADDRESS: STREET 1: 4801 E. WASHINGTON ST CITY: PHOENIX STATE: AZ ZIP: 85034 FORMER COMPANY: FORMER CONFORMED NAME: MAGELLAN HEALTH SERVICES INC DATE OF NAME CHANGE: 19960226 FORMER COMPANY: FORMER CONFORMED NAME: CHARTER MEDICAL CORP DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-04 0 0000019411 MAGELLAN HEALTH INC MGLN 0001244921 WEST JEFFREY N 14100 MAGELLAN PLAZA MARYLAND HEIGHTS MO 63043 0 1 0 0 SVP & Controller Ordinary Common Stock, $0.01 par value 2020-11-04 4 X 0 1298 68.50 A 24313 D Ordinary Common Stock, $0.01 par value 2020-11-04 4 X 0 1183 66.57 A 25496 D Ordinary Common Stock, $0.01 par value 2020-11-04 4 S 0 2481 80.0005 D 23015 D Ordinary Common Stock, $0.01 par value 2020-11-04 4 S 0 139 80.0005 D 22876 D Stock Options (right to buy) 68.50 2020-11-04 4 X 0 1298 0.00 D 2027-03-03 Common Stock 1298 0 D Stock Options (right to buy) 66.57 2020-11-04 4 X 0 1183 0.00 D 2029-03-02 Common Stock 1183 2365 D This transaction was effectuated pursuant to a Rule 10b-5-1 Plan. The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at an average price of $80.0005. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. All of the stock options in this tranche have vested in full. Not applicable. Of the 3,548 stock options in this tranche, 1,183 vested on March 3, 2020 and have been exercised as of the date of reporting. The remainder of 2,365 stock options shall vest in equal increments on March 3, 2021 and 2022. /s/ Jeffrey N. West 2020-11-06